Not applicableLooking for participantsNCT04883905What this trial is testingELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)Who this might be right forAcute Hepatic Porphyria Alnylam Pharmaceuticals 150
Not applicableEnded earlyNCT03547297What this trial is testingINSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHPWho this might be right forAcute Hepatic PorphyriaHepatic PorphyriasAcute Intermittent Porphyria (AIP)+4 more Alnylam Pharmaceuticals 212
Not applicableEnded earlyNCT00680290What this trial is testingThe Effect of Low Intensity Exercise on Quality of Life and Hemodynamics in Patients With Permanent Atrial FibrillationWho this might be right forAtrial Fibrillation University of Texas Southwestern Medical Center 20
Early research (Phase 1)Study completedNCT04608045What this trial is testingSafety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor CicloMed LLC 9
Not applicableActive Not RecruitingNCT05344599What this trial is testingEvaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia SyndromeWho this might be right forPostural Orthostatic Tachycardia SyndromeAcute Hepatic Porphyria Vanderbilt University Medical Center 70
Not applicableStudy completedNCT03906214What this trial is testingEvidence-based Assessment of Medication Sensitivity in Acute Hepatic PorphyriaWho this might be right forPorphyrias University of South Florida 60
Early research (Phase 1)Study completedNCT00004428What this trial is testingPhase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic FibrosisWho this might be right forCystic Fibrosis FDA Office of Orphan Products Development 35
Large-scale testing (Phase 3)Study completedNCT03338816What this trial is testingENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)Who this might be right forAcute Hepatic PorphyriaAcute Intermittent PorphyriaPorphyria, Acute Intermittent+4 more Alnylam Pharmaceuticals 94
Not applicableApproved For MarketingNCT04056481What this trial is testingExpanded Access Protocol of Givosiran for Patients With Acute Hepatic PorphyriaWho this might be right forAcute Hepatic Porphyria Alnylam Pharmaceuticals
Not applicableStudy completedNCT00299195What this trial is testingStudy of Sulindac in Oral Premalignant LesionsWho this might be right forLeukoplakia, OralBenign Neoplasms Memorial Sloan Kettering Cancer Center 63
Testing effectiveness (Phase 2)Ended earlyNCT02922413What this trial is testingPanhematin for Prevention of Acute Attacks of PorphyriaWho this might be right forAcute Intermittent PorphyriaHereditary CoproporphyriaVariegate Porphyria The University of Texas Medical Branch, Galveston 13
Not applicableStudy completedNCT03157076What this trial is testingPilot Study to Investigate the Creation of Physiological Rhythm by Closed Loop Stimulation in hEart Failure pAtients With chronoTropic incompEtenceWho this might be right forHeart FailureCPX Biotronik SE & Co. KG 30
Not applicableUnknownNCT00949195What this trial is testingPulmonary Arterial Pressure Response During ExerciseWho this might be right forCOPD PatientsHealthy SubjectsSemi-supine Echo (SSE)+2 more Szeged University 80
Not applicableStudy completedNCT00737828What this trial is testingCardiopulmonary Exercise Testing and Preoperative Risk StratificationWho this might be right forColorectal CancerAnaesthesiaCritical Illness University College London Hospitals 228
Not applicableUnknownNCT04162054What this trial is testingObservation of Acute Cardiopulmonary Effects in Healthy Individuals Performing Cardiopulmonary Exercise Test (CPX) During Whole Body Vibration (WBV)Who this might be right forAcute Cardiopulmonary Effects Klinikum der Universität Köln 20
Testing effectiveness (Phase 2)Study completedNCT03335267What this trial is testingInvestigator Initiated Trial of CPX-351 for Untreated Acute Myeloid LeukemiaWho this might be right forLeukemia, Myeloid, Acute Weill Medical College of Cornell University 30
Testing effectiveness (Phase 2)Study completedNCT04525131What this trial is testingSafety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder TumorsWho this might be right forBladder Cancer CicloMed LLC 12
Not applicableStudy completedNCT04923516What this trial is testingPrevalence of Acute Hepatic PorphyriaWho this might be right forAcute Hepatic Porphyria Association pour la Recherche en Medecine Interne 150
Not applicableWithdrawnNCT05481814What this trial is testingCPX in Paradoxical Low Flow Aortic StenosisWho this might be right forAortic Valve Stenosis Henry Ford Health System
Not applicableLooking for participantsNCT06349239What this trial is testingOral Azacitidine Maintenance Post-CPX 351Who this might be right forAcute Myeloid Leukemia Centre Hospitalier Universitaire de Nice 100